A Phase I/II Trial of the Metalloporphyrin Radioprotectant BMX-001 in Patients with Newly Diagnosed Head and Neck Cancer Receiving Concurrent Radiation Therapy and Cisplatin
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
A Phase I/II Trial of the Metalloporphyrin Radioprotectant BMX-001 in Patients with Newly Diagnosed Head and Neck Cancer Receiving Concurrent Radiation Therapy and Cisplatin. // International Journal of Radiation Oncology, Biology, Physics. – URL: https://www.sciencedirect.com/science/article/pii/S0360301626044536?dgcid=rss_sd_all
A Phase I/II Trial of the Metalloporphyrin Radioprotectant BMX-001 in Patients with Newly Diagnosed Head and Neck Cancer Receiving Concurrent Radiation Therapy and Cisplatin. International Journal of Radiation Oncology, Biology, Physics. https://www.sciencedirect.com/science/article/pii/S0360301626044536?dgcid=rss_sd_all
“A Phase I/II Trial of the Metalloporphyrin Radioprotectant BMX-001 in Patients with Newly Diagnosed Head and Neck Cancer Receiving Concurrent Radiation Therapy and Cisplatin.” International Journal of Radiation Oncology, Biology, Physics.
@article{article100423,
title = {A Phase I/II Trial of the Metalloporphyrin Radioprotectant BMX-001 in Patients with Newly Diagnosed Head and Neck Cancer Receiving Concurrent Radiation Therapy and Cisplatin},
journal = {International Journal of Radiation Oncology, Biology, Physics},
url = {https://www.sciencedirect.com/science/article/pii/S0360301626044536?dgcid=rss_sd_all}
}